Gregory Cole Davis, Director at BIOANALYTICAL SYSTEMS INC (BASI), bought 5,000 shares at $1.70 ($9K) on 2017-08-18, disclosed to the SEC on 2017-08-23.
Open-market purchase of $8k BASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |